The trial excluded patients who had received blood products within 3 weeks, had renal insufficiency or uncontrolled liver disease, or were pregnant (or planning pregnancy)
Presidente Vitalicio: Álvaro Uribe Vélez Carrera 7 Número 46-91 – Tel: 3004583623 – Bogotá D.C., Colombia
Fundación Centro de Pensamiento Primero Colombia © 2023